U-Chart Analysis:Mochida Pharmaceutical Co.,Ltd.:4534

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Mochida Pharmaceutical Co.,Ltd. Go to web site 4534 Medicals 東証プライム March 1, 2000 1963.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Mochida Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2023年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2022年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2021年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2020年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 47,010 48,415 54,487 53,291 51,032
Other Current AssetsHelp 70,369 73,033 64,306 63,603 64,302
Tangible Fixed AssetsHelp 15,049 14,528 13,299 13,851 13,589
Intangible Fixed AssetHelp 797 713 646 674 372
Investments and OthersHelp 25,606 26,450 29,053 26,069 29,724
Total AssetsHelp 158,831 163,139 161,791 157,488 159,019
Total Current LiabilitiesHelp 31,878 34,493 34,817 36,823 33,909
Total Long-term LiabilitiesHelp 178 0 0 0 0
Shareholder's EquityHelp 126,775 128,646 126,974 120,665 125,110
Total LiabilitiesHelp 158,831 163,139 161,791 157,488 159,019

Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2023年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 103,261 110,179 102,995 101,799 109,643
Total Sales 103,261 110,179 102,995 101,799 109,643
Cost of SalesHelp 48,146 50,626 48,203 49,882 55,477
Other Costs and RevenueHelp 48,466 48,984 46,204 47,319 45,731
Total CostsHelp 96,612 99,610 94,407 97,201 101,208
Net RevenueHelp 55,115 59,553 54,792 51,917 54,166
Earnings Before TaxHelp 9,044 14,591 11,900 6,273 11,642
Net IncomeHelp 6,649 10,569 8,588 4,598 8,435
Net Income 6,649 10,569 8,588 4,598 8,435

Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2023年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 7,297 7,460 9,196 9,347 12,564
Investing Cash Flow(ICF)Help -2,949 -2,007 -880 -1,760 -1,121
Financing Cash FlowHelp -6,884 -5,956 -5,112 -5,328 -6,094
Exchange Difference of Cash and Cash EquivalentsHelp 32 31 -9 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -2,504 -472 3,195 2,259 5,349

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Mochida Pharmaceutical Co.,Ltd.

Company where related level is highHelp

MIKASA SEIYAKU CO.,LTD.
Delta-Fly Pharma,Inc.
Solasia Pharma K.K.
SANTEN PHARMACEUTICAL CO.,LTD.
Cuorips Inc.
NANO MRNA Co., Ltd.
TMS Co.,Ltd.
KAKEN PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Holdings Co., Ltd.
Nissui Pharmaceutical Co.,Ltd.